Comparison of Vancomycin Pharmacokinetics in Cystic Fibrosis Patients Pre and Post-lung Transplant

BACKGROUND: Vancomycin is commonly used to treat acute cystic fibrosis (CF) exacerbations associated with methicillin-resistant Staphylococcus aureus (MRSA). Multiple studies have demonstrated pharmacokinetic differences of antimicrobials in the CF population. Very little data exist regarding pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Shannon, Sakon, Colleen, Fitzgerald, Linda, Kam, Charissa, McDade, Erin, Wong, Alanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297476/
https://www.ncbi.nlm.nih.gov/pubmed/32595284
http://dx.doi.org/10.1177/1179548420930925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297476/
https://www.ncbi.nlm.nih.gov/pubmed/32595284
http://dx.doi.org/10.1177/1179548420930925

Ejemplares similares